Advertisement
Australia markets close in 56 minutes
  • ALL ORDS

    7,794.50
    -104.40 (-1.32%)
     
  • ASX 200

    7,543.40
    -98.70 (-1.29%)
     
  • AUD/USD

    0.6398
    -0.0028 (-0.43%)
     
  • OIL

    84.47
    +1.74 (+2.10%)
     
  • GOLD

    2,397.80
    -0.20 (-0.01%)
     
  • Bitcoin AUD

    97,127.52
    +827.82 (+0.86%)
     
  • CMC Crypto 200

    1,289.25
    +403.71 (+44.47%)
     
  • AUD/EUR

    0.6014
    -0.0016 (-0.27%)
     
  • AUD/NZD

    1.0880
    +0.0005 (+0.05%)
     
  • NZX 50

    11,756.31
    -79.73 (-0.67%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,197.39
    -188.48 (-1.15%)
     
  • NIKKEI 225

    37,024.77
    -1,054.93 (-2.77%)
     

Is It Too Late to Buy AbbVie Stock?

Is It Too Late to Buy AbbVie Stock?

Pharma giant AbbVie (NYSE: ABBV) has rewarded shareholders in the past decade with market-beating performance. AbbVie's strong showing was primarily a result of its top-selling drug, Humira. If the company manages to replace the medicine, it could deliver many more years of solid performances.